Advanced search
Publication Cover
Leukemia & Lymphoma Volume 58, 2017 - Issue 5
Submit an article Journal homepage
1,256
Views
17
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Cladribine, cytarabine and idarubicin (CLA-Ida) salvage chemotherapy in relapsed acute myeloid leukemia (AML)

Chantal FridleDepartment of Medical Oncology, University Hospital Berne and University of Berne, Berne, Switzerland;
,
Michael MedingerDepartment of Hematology, University Hospital, Basel, Switzerland;
,
Matthias C. WilkDivision of Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland;
,
Katja SeipelDepartment of Clinical Research, University of Berne, Berne, Switzerland
,
Jakob PasswegDepartment of Hematology, University Hospital, Basel, Switzerland;
,
Markus G. ManzDivision of Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland;
&
Thomas PabstDepartment of Medical Oncology, University Hospital Berne and University of Berne, Berne, Switzerland; Correspondence[email protected]
 show all
Pages 1068-1075 | Received 04 Jun 2016, Accepted 05 Sep 2016, Published online: 13 Oct 2016

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Muhammad Umair Mushtaq, Alexandra M. Harrington, Sibgha Gull Chaudhary, Laura C. Michaelis, Karen-Sue B. Carlson, Sameem Abedin, Lyndsey Runass, Natalie S. Callander, Michael J. Fallon, Mark Juckett, Aric C. Hall, Peiman Hematti, Ryan J. Mattison, Ehab L. Atallah & Guru Subramanian Guru Murthy. (2021) Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemia. Leukemia & Lymphoma 62:1, pages 158-166.
Read now
Maria Galkin & Brian A Jonas. (2019) Enasidenib in the treatment of relapsed/refractory acute myeloid leukemia: an evidence-based review of its place in therapy. Core Evidence 14, pages 3-17.
Read now
Priska Fassbind, Barbara Jeker, Beatrice U. Mueller, Ulrike Bacher, Stefan Zimmerli, Olga Endrich, Brigitta Gahl, Urban Novak & Thomas Pabst. (2019) Improved survival rates of AML patients following admission to the intensive care unit. Leukemia & Lymphoma 60:10, pages 2423-2431.
Read now

Articles from other publishers (14)

Han Yao, Cheng Zhang, Xu Tan, Jieping Li, Xiaolin Yin, Xiaojuan Deng, Ting Chen, Jun Rao, Lei Gao, Peiyan Kong & Xi Zhang. (2023) Efficacy and toxicity of CLAG combined with pegylated liposomal doxorubicin in the treatment of refractory or relapsed acute myeloid leukemia . Cancer Medicine 12:11, pages 12377-12387.
Crossref
Fenglin Wang, Min Xie, Pan Chen, Dan Wang & Minghua Yang. (2022) Homoharringtonine combined with cladribine and aclarubicin (HCA) in acute myeloid leukemia: A new regimen of conventional drugs and its mechanism. Oxidative Medicine and Cellular Longevity 2022, pages 1-12.
Crossref
Gregory W. Roloff, Olatoyosi Odenike, Ashish Bajel, Andrew H. Wei, Nicole Foley & Geoffrey L. Uy. (2022) Contemporary Approach to Acute Myeloid Leukemia Therapy in 2022. American Society of Clinical Oncology Educational Book:42, pages 568-583.
Crossref
Evgenii Shumilov, Inna Shakhanova, Johanna Flach, Nicole Schmidt, Susanne Buerki, Myriam Legros, Marie-Noëlle Kronig, Yishai Ofran, Sabine Gerull, Michael Medinger, Behrouz Mansouri Taleghani, Jakob Passweg, Jörg Halter, Ulrike Bacher & Thomas Pabst. (2021) Feasibility and efficacy of salvage allogeneic stem cell transplantation in AML patients relapsing after autologous stem cell transplantation. Bone Marrow Transplantation 57:2, pages 224-231.
Crossref
Silvia Park, Daehun Kwag, Tong Yoon Kim, Jong Hyuk Lee, Joon yeop Lee, Gi June Min, Sung Soo Park, Seung-Ah Yahng, Young-Woo Jeon, Seung-Hwan Shin, Jae-Ho Yoon, Sung-Eun Lee, Byung Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee & Hee-Je Kim. (2022) A retrospective comparison of salvage intensive chemotherapy versus venetoclax-combined regimen in patients with relapsed/refractory acute myeloid leukemia (AML) . Therapeutic Advances in Hematology 13, pages 204062072210816.
Crossref
Shandong Tao, Lixiao Song, Yuan Deng, Yue Chen, Yimin Gan, Yunjie Li, Yihan Ding, Zhe Zhang, Banghe Ding, Zhengmei He, Chunling Wang & Liang Yu. (2021) Successful treatment of two relapsed patients with t(11;19)(q23;p13) acute myeloid leukemia by CLAE chemotherapy sequential with allogeneic hematopoietic stem cell transplantation: Case reports. Oncology Letters 21:3.
Crossref
Farhad Ravandi, Sherry Pierce, Guillermo Garcia-Manero, Tapan Kadia, Elias Jabbour, Gautam Borthakur, Courtney D. DiNardo, Naval Daver, Nicholas J. Short, Yesid Alvarado, Jorge Cortes, Christopher Kim, Michael Kelsh, Aaron Katz, Richard Williams, Zhao Yang, Bhakti Mehta & Hagop Kantarjian. (2020) Salvage Therapy Outcomes in a Historical Cohort of Patients With Relapsed or Refractory Acute Myeloid Leukemia. Clinical Lymphoma Myeloma and Leukemia 20:11, pages e871-e882.
Crossref
Julia N Artsemyeva, Ekaterina A Remeeva, Tatiana N Buravskaya, Irina D Konstantinova, Roman S Esipov, Anatoly I Miroshnikov, Natalia M Litvinko & Igor A Mikhailopulo. (2020) Anion exchange resins in phosphate form as versatile carriers for the reactions catalyzed by nucleoside phosphorylases. Beilstein Journal of Organic Chemistry 16, pages 2607-2622.
Crossref
Karin Mayer, Corinna Hahn‐Ast, Katjana Schwab, Ingo G. H. Schmidt‐Wolf, Peter Brossart, Axel Glasmacher & Marie Lilienfeld‐Toal. (2020) Long‐term follow‐up of Cladribine, high‐dose Cytarabine, and Idarubicin as salvage treatment for relapsed acute myeloid leukemia and literature review. European Journal of Haematology 104:6, pages 538-545.
Crossref
Na Zhang, Jing-Bo Shao, Hong Li, Jing-Wei Yang, Kai Chen, Jia-Shi Zhu & Hui Jiang. (2019) Re-induction with modified CLAG regimen in relapsed or refractory acute myeloid leukemia in children bridging to allogeneic hematopoietic stem cell transplantation. World Journal of Pediatrics 16:2, pages 152-158.
Crossref
Wellington Fernandes da Silva, Lidiane Inês da Rosa, Fernanda Salles Seguro, Douglas Rafaele Almeida Silveira, Israel Bendit, Valeria Buccheri, Elvira Deolinda Rodrigues Pereira Velloso, Vanderson Rocha & Eduardo M Rego. (2020) Salvage treatment for refractory or relapsed acute myeloid leukemia: a 10-year single-center experience. Clinics 75, pages e1566.
Crossref
Hyun Don Yun & Celalettin Ustun. 2020. Mastocytosis. Mastocytosis 231 255 .
Kirsten M. KnechtOlga BuzovetskyConstanze SchneiderDominique ThomasVishok SrikanthLars KaderaliFlorentina TofoleanuKrystle ReissNerea FerreirósGerd GeisslingerVictor S. Batista, Xiaoyun JiJindrich CinatlJr.Jr., Oliver T. Keppler & Yong Xiong. (2018) The structural basis for cancer drug interactions with the catalytic and allosteric sites of SAMHD1. Proceedings of the National Academy of Sciences 115:43.
Crossref
. (2017) Cladribine/cytarabine/idarubicin. Reactions Weekly 1647:1, pages 94-94.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.